chr12-122208411-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001371333.1(DIABLO):​c.690G>A​(p.Ser230Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0177 in 1,613,036 control chromosomes in the GnomAD database, including 3,788 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.089 ( 1974 hom., cov: 32)
Exomes 𝑓: 0.010 ( 1814 hom. )

Consequence

DIABLO
NM_001371333.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.45

Publications

6 publications found
Variant links:
Genes affected
DIABLO (HGNC:21528): (diablo IAP-binding mitochondrial protein) This gene encodes an inhibitor of apoptosis protein (IAP)-binding protein. The encoded mitochondrial protein enters the cytosol when cells undergo apoptosis, and allows activation of caspases by binding to inhibitor of apoptosis proteins. Overexpression of the encoded protein sensitizes tumor cells to apoptosis. A mutation in this gene is associated with young-adult onset of nonsyndromic deafness-64. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2013]
B3GNT4 (HGNC:15683): (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4) This gene encodes a member of the beta-1,3-N-acetylglucosaminyltransferase protein family. The encoded enzyme is involved in the biosynthesis of poly-N-acetyllactosamine chains and prefers lacto-N-neotetraose as a substrate. It is a type II transmembrane protein. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 12-122208411-C-T is Benign according to our data. Variant chr12-122208411-C-T is described in ClinVar as Benign. ClinVar VariationId is 226562.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.45 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.302 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DIABLONM_001371333.1 linkc.690G>A p.Ser230Ser synonymous_variant Exon 6 of 6 ENST00000464942.7 NP_001358262.1
B3GNT4NM_030765.4 linkc.*1023C>T 3_prime_UTR_variant Exon 3 of 3 ENST00000324189.5 NP_110392.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DIABLOENST00000464942.7 linkc.690G>A p.Ser230Ser synonymous_variant Exon 6 of 6 1 NM_001371333.1 ENSP00000442360.2
ENSG00000256861ENST00000535844.1 linkn.*484G>A non_coding_transcript_exon_variant Exon 16 of 16 2 ENSP00000454454.1
B3GNT4ENST00000324189.5 linkc.*1023C>T 3_prime_UTR_variant Exon 3 of 3 1 NM_030765.4 ENSP00000319636.4
ENSG00000256861ENST00000535844.1 linkn.*484G>A 3_prime_UTR_variant Exon 16 of 16 2 ENSP00000454454.1

Frequencies

GnomAD3 genomes
AF:
0.0891
AC:
13550
AN:
152112
Hom.:
1969
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.306
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0353
Gnomad ASJ
AF:
0.0291
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00141
Gnomad OTH
AF:
0.0583
GnomAD2 exomes
AF:
0.0247
AC:
6148
AN:
249380
AF XY:
0.0185
show subpopulations
Gnomad AFR exome
AF:
0.313
Gnomad AMR exome
AF:
0.0167
Gnomad ASJ exome
AF:
0.0259
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00143
Gnomad OTH exome
AF:
0.0123
GnomAD4 exome
AF:
0.0103
AC:
15000
AN:
1460806
Hom.:
1814
Cov.:
31
AF XY:
0.00901
AC XY:
6550
AN XY:
726642
show subpopulations
African (AFR)
AF:
0.328
AC:
10966
AN:
33450
American (AMR)
AF:
0.0181
AC:
811
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0287
AC:
749
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00128
AC:
110
AN:
86072
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53142
Middle Eastern (MID)
AF:
0.0165
AC:
87
AN:
5262
European-Non Finnish (NFE)
AF:
0.000789
AC:
877
AN:
1112002
Other (OTH)
AF:
0.0232
AC:
1398
AN:
60318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
747
1494
2242
2989
3736
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
344
688
1032
1376
1720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0892
AC:
13583
AN:
152230
Hom.:
1974
Cov.:
32
AF XY:
0.0865
AC XY:
6435
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.306
AC:
12712
AN:
41492
American (AMR)
AF:
0.0353
AC:
540
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0291
AC:
101
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00141
AC:
96
AN:
68010
Other (OTH)
AF:
0.0577
AC:
122
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
484
968
1451
1935
2419
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0397
Hom.:
532
Bravo
AF:
0.103
EpiCase
AF:
0.00207
EpiControl
AF:
0.00172

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jul 09, 2020
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 28, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ser230Ser in exon 7 of DIABLO: This variant is not expected to have clinical s ignificance because it has been identified in 31.1% (3168/10204) of African chro mosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.or g; dbSNP rs35426428). -

Oct 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
1.5
DANN
Benign
0.60
PhyloP100
-2.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35426428; hg19: chr12-122692958; API